LCN2 and chronic kidney disease: In a subgroup analysis, plasma NGAL levels were significantly upregulated in CKD patients who developed CI‐AKI at 6, 24, 48 and 72 h after receiving a contrast media, and there was no different among visits (p < 0.05 vs. baseline, Figure 5A).